Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial
about
sameAs
Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization.The Risk of Atrial Fibrillation With Ivabradine Treatment: A Meta-analysis With Trial Sequential Analysis of More Than 40000 PatientsIvabradine, coronary artery disease, and heart failure: beyond rhythm controlComparison of the efficacy and tolerability of ivabradine and ranolazine in patients of chronic stable angina pectorisManagement standards for stable coronary artery disease in India.Ivabradine in combination with Beta-blockers in patients with chronic stable angina after percutaneous coronary intervention.ANMCO/GICR-IACPR/SICI-GISE Consensus Document: the clinical management of chronic ischaemic cardiomyopathyIvabradine: the evidence of its therapeutic impact in angina.Ivabradine treatment in a chronic heart failure patient cohort: symptom reduction and improvement in quality of life in clinical practiceDrugs and their molecular targets: an updated overview.Efficacy of the I(f) current inhibitor ivabradine in patients with chronic stable angina receiving beta-blocker therapy: a 4-month, randomized, placebo-controlled trial.Recurrent angina after coronary angioplasty: mechanisms, diagnostic and therapeutic options.F 15845 inhibits persistent sodium current in the heart and prevents angina in animal modelsEffectiveness and Tolerability of Ivabradine with or Without Concomitant Beta-Blocker Therapy in Patients with Chronic Stable Angina in Routine Clinical Practice.The Role of Ivabradine in the Management of Angina Pectoris.Focus on ivabradine: a new heart rate-controlling drug.Controversies in cardiovascular medicine: Chronic stable coronary artery disease: drugs vs. revascularization.Emerging medical treatment for angina pectoris.Rate control with ivabradine: angina pectoris and beyond.Emerging drugs for coronary artery disease. From past achievements and current needs to clinical promises.Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.Cardioprotection by ivabradine through heart rate reduction and beyond.Selective and specific I(f) inhibition with ivabradine: new perspectives for the treatment of cardiovascular disease.'Inappropriate' sinus tachycardia: does the 100 beats per min cut-off matter?Selective and specific inhibition of If with ivabradine for the treatment of coronary artery disease or heart failure.An evaluation of the pharmacokinetics and pharmacodynamics of ivabradine for the treatment of heart failure.Ivabradine: a new rate-limiting therapy for coronary artery disease and heart failure.Ivadradine.Heart rate and its reduction in chronic heart failure and beyond.Current Role of Ivabradine in Stable Coronary Artery Disease Without Heart Failure.Role of Ivabradine in the Treatment of Patients With Cardiovascular Disease.Ranolazine and Ivabradine: two different modalities to act against ischemic heart disease.Ivabradine: Cardioprotection By and Beyond Heart Rate Reduction.Management of Stable Angina - Current Guidelines: A Critical Appraisal.Antianginal Therapy for Stable Ischemic Heart Disease.Gender differences in the effects of cardiovascular drugs.Management of stable angina: A commentary on the European Society of Cardiology guidelines.Atrial fibrillation associated with ivabradine treatment: meta-analysis of randomised controlled trials.Pleiotropic, heart rate-independent cardioprotection by ivabradine.Short-term effects of ivabradine in patients with chronic stable ischemic heart disease.
P2860
Q24605881-F5CC0063-5519-4C21-A21F-BCDB591855A9Q26741956-5DA094DE-0FB4-489B-B592-90CE6D82C961Q26865770-6B56FA25-EE86-495E-83EE-FF959CBC481AQ28706249-48C02E9B-D531-447C-8B20-408805054656Q30239853-E497D679-36E1-439E-9EBF-7631FC6EB82EQ30316766-CE10AC41-5192-4F90-96AC-1438EEA9ECF7Q33647497-B1049E0B-970D-4242-B74E-CC8E04D56BB2Q33973963-39D27B8B-A2A1-4B44-AA4F-F1C71785EE23Q34253493-F9CFCBD0-5E57-4B2B-9463-55D3773F4F52Q34746522-FB6E540E-842A-4510-B0EA-81776A4FC486Q37112685-E6F5EE92-9AB0-4231-AF59-F1CE34B9C397Q37140881-70912975-6F29-426A-9912-CE61E5370E6AQ37231007-4CB722B2-92B7-48E6-8063-41A01C38B009Q37250491-D53BF822-771A-4126-8977-008A53EA6168Q37298004-F0EF2AF2-10CB-48EF-9131-2F721F158DB5Q37390737-7270190E-A5A6-4952-8CA6-0692AEFCF111Q37682501-42A0F372-22CE-4CCF-A184-BF06EF03EA53Q37729183-D5B57478-563C-49C9-B6DD-ED96CD3016A6Q37810893-B7C4A44C-BF1B-43C4-8C27-6219C6CFDA30Q37827882-7A73CD35-B315-451F-852B-81B63E9A8AB7Q37857335-E1509678-C9D5-444A-A255-D841286150C6Q37912844-E859B01F-1E5F-482D-B0BB-24E6FB268328Q37923966-21F0FCA3-4F76-4DC8-A2EC-B4D073F2DB54Q38086846-17E0D312-1C1F-4C93-B14A-6E9D20E4606DQ38142792-F9ED858B-59B8-457D-9EA4-A4AA93238B01Q38174653-D714EC94-E4BB-4412-8AFC-97540E6B5E18Q38235948-81BF2A7C-0492-46C9-BACD-DF111FF71E47Q38368879-48046D45-DFA3-4025-A918-CD97FB318CFDQ38669556-066D9BC1-6CFF-46AF-A0ED-7108B274DC0EQ38697074-1EAD6B32-0478-4DAC-8226-8DAE32C422A1Q38751093-5E145F91-8024-4FA6-A143-F833D8305097Q38761008-1190BDB4-F2C7-4D06-BBF2-9E5A78A0AE3DQ38797276-396FD2FA-38B2-470F-B634-8DEACFC2D1F6Q38957123-71B4CA77-D928-4B50-AC4E-CED9734FDA18Q39157629-98D5765F-E7E6-4F1D-BE1B-446CF2494164Q39193538-F4E5E167-B00C-43F2-BB08-71D7346D9A4BQ39738089-C7A29E8A-E7AF-4D01-9832-DFDA7543245CQ42004610-7DF36F8A-570B-48FF-BB89-EEB56C97D594Q42205768-67D8E3B1-47D0-4EA3-B198-292DC1362F93Q42568652-BA23599F-362F-4C8F-A0C7-8041AEF2AC28
P2860
Antianginal efficacy and safety of ivabradine compared with amlodipine in patients with stable effort angina pectoris: a 3-month randomised, double-blind, multicentre, noninferiority trial
description
2007 nî lūn-bûn
@nan
2007 թուականին հրատարակուած գիտական յօդուած
@hyw
2007 թվականին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
name
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@ast
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@en
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@nl
type
label
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@ast
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@en
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@nl
altLabel
Antianginal Efficacy and Safet ...... Stable Effort Angina Pectoris
@ast
Antianginal Efficacy and Safet ...... Stable Effort Angina Pectoris
@en
prefLabel
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@ast
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@en
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@nl
P2093
P3181
P1433
P1476
Antianginal Efficacy and Safet ...... Stable Effort Angina Pectoris
@en
Antianginal efficacy and safet ...... ticentre, noninferiority trial
@en
P2093
Witold Ruzyllo
P2860
P304
P3181
P356
10.2165/00003495-200767030-00005
P407
P577
2007-01-01T00:00:00Z
P6179
1026439254